Effects of BRCA1 and BRCA2 mutations on female fertility

Department of Family and Consumer Studies, University of Utah, 225 South 1400 East Alfred Emery Building 228, Salt Lake City, UT 84112, USA.
Proceedings of the Royal Society B: Biological Sciences (Impact Factor: 5.05). 04/2012; 279(1732):1389-95. DOI: 10.1098/rspb.2011.1697
Source: PubMed


Women with BRCA1/2 mutations have a significantly higher lifetime risk of developing breast or ovarian cancer. We suggest that female mutation carriers may have improved fitness owing to enhanced fertility relative to non-carriers. Here we show that women who are carriers of BRCA1/2 mutations living in natural fertility conditions have excess fertility as well as excess post-reproductive mortality in relation to controls. Individuals who tested positive for BRCA1/2 mutations who linked into multi-generational pedigrees within the Utah Population Database were used to identify putative obligate carriers. We find that women born before 1930 who are mutation carriers have significantly more children than controls and have excess post-reproductive mortality risks. They also have shorter birth intervals and end child-bearing later than controls. For contemporary women tested directly for BRCA1/2 mutations, an era when modern contraceptives are available, differences in fertility and mortality persist but are attenuated. Our findings suggest the need to re-examine the wider role played by BRCA1/2 mutations. Elevated fertility of female mutation carriers indicates that they are more fecund despite their elevated post-reproductive mortality risks.

Download full-text


Available from: Ken R Smith,
    • "For example, in Xiphophorus fish, melanoma-promoting oncogene alleles are associated with larger body size and aggressiveness and confer early life advantages in malemale competition and female mate choice (see Fernandez and Bowser, 2010; Fernandez and Morris, 2008). Women with BRCA1/2 mutations have a significantly higher lifetime risk of developing breast or ovarian cancer, but elevated fertility of mutation carriers indicates that these women are also more fecund despite their elevated post-reproductive mortality risks (Smith et al. 2012). It has also been suggested that the maintenance of ICMA can be a This article is protected by copyright. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Similar to seemingly maladaptive genes in general, the persistence of inherited cancer-causing mutant alleles in populations remains a challenging question for evolutionary biologists. In addition to traditional explanations like senescence or antagonistic pleiotropy, here we put forward a new hypothesis to explain the retention of oncogenic mutations. We propose that while natural defenses evolve to prevent neoplasm formation and progression thus increasing organismal fitness, they also conceal the effects of cancer-causing mutant alleles on fitness and concomitantly protect inherited ones from purging by purifying selection. We also argue for the importance of the ecological contexts experienced by individuals and/or species. These contexts determine the locally predominant fitness-reducing risks, and hence can aid the prediction of how natural selection will influence cancer outcomes. This article is protected by copyright. All rights reserved.
    Evolution 10/2015; DOI:10.1111/evo.12809 · 4.61 Impact Factor
  • Source
    • "In the context of cancer, this phenomenon antagonistic pleiotropy -has been found in animal models, perhaps the most stunning case being Xiphophorus fish, where late life melanoma-promoting oncogene alleles are associated with early life advantages (Fernandez and Bowser 2010). There is increasing evidence that some human cancers occurring at later ages may result from negative trade-offs with early age adaptations (Summers and Crespi 2008, 2010; Smith et al. 2012), such as, for instance, high birth weight – a life-history trait that has a genetic basis and is also associated with fitness benefits early in life (e.g., survival until maturity, Thomas et al. 2012b; Smith et al. 2012). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Since the mid 1970s, cancer has been described as a process of Darwinian evolution, with somatic cellular selection and evolution being the fundamental processes leading to malignancy and its many manifestations (neoangiogenesis, evasion of the immune system, metastasis, and resistance to therapies). Historically, little attention has been placed on applications of evolutionary biology to understanding and controlling neoplastic progression and to prevent therapeutic failures. This is now beginning to change, and there is a growing international interest in the interface between cancer and evolutionary biology. The objective of this introduction is first to describe the basic ideas and concepts linking evolutionary biology to cancer. We then present four major fronts where the evolutionary perspective is most developed, namely laboratory and clinical models, mathematical models, databases, and techniques and assays. Finally, we discuss several of the most promising challenges and future prospects in this interdisciplinary research direction in the war against cancer.
    Evolutionary Applications 01/2013; 6(1):1-10. DOI:10.1111/eva.12021 · 3.90 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Most early evolutionary thinkers came from medicine, yet evolution has had a checkered history in medical education. It is only in the last few decades that serious efforts have begun to be made to integrate evolutionary biology into the medical curriculum. However, it is not clear when, where (independently or as part of preclinical or clinical teaching courses) and, most importantly, how should medical students learn the basic principles of evolutionary biology applied to medicine, known today as evolutionary or Darwinian medicine. Most clinicians are ill-prepared to teach evolutionary biology and most evolutionary biologists ill-equipped to formulate clinical examples. Yet, if evolutionary science is to have impact on clinical thought, then teaching material that embeds evolution within the clinical framework must be developed. In this paper, we use two clinical case studies to demonstrate how such may be used to teach evolutionary medicine to medical students in a way that is approachable as well as informative and relevant. KeywordsEvolutionary medicine–Curriculum–Medical education–Case study–Scurvy–Cancers of female reproductive tract–Medical students
    Evolution Education and Outreach 12/2011; 4(4):595-602. DOI:10.1007/s12052-011-0374-x
Show more